Effect of theophylline on induced sputum inflammatory indices and neutrophil chemotaxis in chronic obstructive pulmonary disease

American Journal of Respiratory and Critical Care Medicine

Volumn 165, Issue 10, 2002, Pages 1371-1376

  Culpitt, Sarah V ^a   De Matos, Carmen ^a   Russell, Richard E ^a   Donnelly, Louise E ^a   Rogers, Duncan F ^a   Barnes, Peter J ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Chemotaxis; COPD; Neutrophil; Sputum; Theophylline

Indexed keywords

CHEMOATTRACTANT; FORMYLMETHIONYLLEUCYLPHENYLALANINE; INTERLEUKIN 8; LACTOFERRIN; MYELOPEROXIDASE; PLACEBO; THEOPHYLLINE;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; HUMAN; HUMAN CELL; INFLAMMATION; INFLAMMATORY CELL; LONG TERM CARE; NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SPUTUM EXAMINATION; THEOPHYLLINE BLOOD LEVEL; TREATMENT OUTCOME; AGED; COMPARATIVE STUDY; CYTOLOGY; DRUG ADMINISTRATION; FEMALE; HOSPITALIZATION; MALE; MIDDLE AGED; NEUTROPHIL; NONPARAMETRIC TEST; PHYSIOLOGY; PROBABILITY; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY; SPIROMETRY; SPUTUM;

AGED; CHEMOTAXIS, LEUKOCYTE; COMPARATIVE STUDY; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMAN; MALE; MIDDLE AGE; NEUTROPHILS; PROBABILITY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SPIROMETRY; SPUTUM; STATISTICS, NONPARAMETRIC; THEOPHYLLINE; HUMANS; MIDDLE AGED;

EID: 0037092557     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/rccm.2105106     Document Type: Article

References (60)

1. Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study
2. Evaluation of current pharmacotherapy of chronic obstructive pulmonary disease
3. Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma
4. The role of proteinases in the pathogenesis of chronic bronchitis
5. Balance of matrix metalloprotease-9 and tissue inhibitor of metalloprotease-1 from alveolar macrophages in cigarette smokers. Regulation by interleukin-10
6. Oxidative stress in chronic obstructive pulmonary disease
7. The activity of cytochrome oxidase is increased in circulating lymphocytes of patients with chronic obstructive pulmonary disease, asthma, and chronic arthritis
8. CD8+ve cells in the lungs of smokers with chronic obstructive pulmonary disease
9. Airway inflammation in nonobstructive and obstructive chronic bronchitis with chronic haemophilus influenzae airway infection. Comparison with noninfected patients with chronic obstructive pulmonary disease
10. Role of sputum differential cell count in detecting airway inflammation in patients with chronic bronchial asthma or COPD
11. 1 in smokers are associated with increased levels of sputum neutrophils
12. Granulocyte activation markers in induced sputum: Comparison between chronic obstructive pulmonary disease, asthma, and normal subjects
13. Interleukin-8 induces neutrophil transendothelial migration
14. Interleukin-8: An important chemoattractant in sputum of patients with chronic inflammatory airway diseases
15. The chemotactic activity of sputum from patients with bronchiectasis
16. The interrelationship of sputum inflammatory markers in patients with chronic bronchitis
17. Interleukin-8 gene expression in human bronchial epithelial cells
18. Leukocyte recruitment by monocyte chemotactic proteins (MCPs) secreted by human phagocytes
19. Effect of granulocyte-macrophage colony-stimulating factor and interleukin-3 on interleukin-8 production by human neutrophils and monocytes
20. Theophylline and selective PDE inhibitors as bronchodilators and smooth muscle relaxants
21. Effects of theophylline on diaphragmatic strength and fatigue in patients with chronic obstructive pulmonary disease
22. A randomized, controlled trial of theophylline in patients with severe chronic obstructive pulmonary disease
23. Dose response relation to oral theophylline in severe chronic obstructive airways disease
24. Theophylline and mucociliary function
25. Immunomodulation by theophylline in asthma
26. Theophylline modulation of E-rosette formation: An indicator of T-cell maturation
27. Differential effects of non-selective and selective phosphodiesterase inhibitors on human eosinophil functions
28. Effect of theophylline on the production of interleukin-1 beta, tumor necrosis factor-alpha, and interleukin-8 by human peripheral blood mononuclear cells
29. Anti-inflammatory effects of theophylline: Modulation of cytokine production
30. Effects of theophylline and rolipram on leukotriene C4 (LTC4) synthesis and chemotaxis of human eosinophils from normal and atopic subjects
31. Phosphodiesterase and cyclic adenosine monophosphate-dependent inhibition of T-lymphocyte chemotaxis
32. Theophylline therapy inhibits neutrophil and mononuclear cell chemotaxis from chronic asthmatic children
33. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease
34. Effect of high dose inhaled steroid on cells, cytokines and proteases in induced sputum in COPD
35. Treatment of patients with chronic airways obstruction: A controlled study with bamyphylline
36. Theophylline and salbutamol improve pulmonary function in patients with irreversible chronic obstructive pulmonary disease
37. Factor analysis of changes in dyspnea and lung function parameters after bronchodilation in chronic obstructive pulmonary disease
38. Relation of FEV(1) to clinical outcomes during exacerbations of chronic obstructive pulmonary disease
39. Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD
40. Effects of human neutrophil elastase and Pseudomonas aeruginosa proteinases on human respiratory epithelium
41. Increased neutrophil myeloperoxidase activity associated with cigarette smoking
42. Alterations in leukocyte oxidative metabolism in cigarette smokers
43. Expression and biology of neutrophil and endothelial cell-derived chemokines
44. The relationship between chronic hypoxemia and activation of the tumor necrosis factor-alpha system in patients with chronic obstructive pulmonary disease
45. Long-acting bronchodilation with once-daily dosing of tiotropium (Spiriva) in stable chronic obstructive pulmonary disease
46. The effects of oxitropium bromide on exercise performance in patients with stable chronic obstructive pulmonary disease. A comparison of three different exercise tests
47. Withdrawal of chronic systemic corticosteroids in patients with COPD: A randomized trial
48. Inhaled corticosteroids are beneficial in chronic obstructive pulmonary disease
49. Inhaled corticosteroids are not beneficial in chronic obstructive pulmonary disease
50. Rebuttal
51. Rebuttal
52. Procaterol inhibits IL-1beta- and TNF-alpha-mediated epithelial cell eosinophil chemotactic activity
53. Neutrophils from subjects with chronic obstructive lung disease show enhanced chemotaxis and extracellular proteolysis
54. Chemotactic factor-induced polarization, receptor redistribution, and locomotion of human blood monocytes
55. Degree of neutrophil chemotaxis is dependent upon the chemoattractant and barrier
56. Neutrophil chemotaxis to leukotriene B4 in vitro is decreased for the human neonate
57. The influence of aminophylline on human neutrophils - Possible protection of lung from proteolytic injury
58. Effects of theophylline on human eosinophil functions: Comparative study with neutrophil functions
59. The effects of beta 2-agonists and methylxanthines on neutrophil function in vitro
60. Comparative differences and combined effects of interleukin-8, leukotriene B4, and platelet-activating factor on neutrophil chemotaxis of the newborn